Literature DB >> 23656757

Blocking the attachment of cancer cells in vivo with DNA aptamers displaying anti-adhesive properties against the carcinoembryonic antigen.

Erik W Orava1, Aws Abdul-Wahid, Eric H-B Huang, Amirul Islam Mallick, Jean Gariépy.   

Abstract

The formation of metastatic foci occurs through a series of cellular events, initiated by the attachment and aggregation of cancer cells leading to the establishment of micrometastases. We report the derivation of synthetic DNA aptamers bearing anti-adhesive properties directed at cancer cells expressing the carcinoembryonic antigen (CEA). Two DNA aptamers targeting the homotypic and heterotypic IgV-like binding domain of CEA were shown to block the cell adhesion properties of CEA, while not recognizing other IgV-like domains of CEACAM family members that share strong sequence and structural homologies. More importantly, the pre-treatment of CEA-expressing tumour cells with these aptamers prior to their intraperitoneal implantation resulted in the prevention of peritoneal tumour foci formation. Taken together, these results highlight the effectiveness of targeting the cell adhesion properties of cancer cells with aptamers in preventing tumour implantation.
Copyright © 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adhesion; CEA; DNA aptamers; Homotypic binding; Metastatic cancer

Mesh:

Substances:

Year:  2013        PMID: 23656757      PMCID: PMC5528425          DOI: 10.1016/j.molonc.2013.03.005

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  70 in total

Review 1.  ANTI-ADHESION evolves to a promising therapeutic concept in oncology.

Authors:  R Schmidmaier; P Baumann
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

2.  Selection of aptamers against live bacterial cells.

Authors:  Camille L A Hamula; Hongquan Zhang; Le Luo Guan; Xing-Fang Li; X Chris Le
Journal:  Anal Chem       Date:  2008-09-20       Impact factor: 6.986

3.  Role of carbohydrate structures in CEA-mediated intercellular adhesion.

Authors:  J Charbonneau; C P Stanners
Journal:  Cell Adhes Commun       Date:  1999

4.  Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule.

Authors:  S Benchimol; A Fuks; S Jothy; N Beauchemin; K Shirota; C P Stanners
Journal:  Cell       Date:  1989-04-21       Impact factor: 41.582

5.  Carcinoembryonic antigen induction of IL-10 and IL-6 inhibits hepatic ischemic/reperfusion injury to colorectal carcinoma cells.

Authors:  John Milburn Jessup; Luciana Laguinge; Shuling Lin; Raed Samara; Kimberly Aufman; Paul Battle; Marilyn Frantz; Kirsten H Edmiston; Peter Thomas
Journal:  Int J Cancer       Date:  2004-09-01       Impact factor: 7.396

Review 6.  Carcinoembryonic antigen gene family: molecular biology and clinical perspectives.

Authors:  J A Thompson; F Grunert; W Zimmermann
Journal:  J Clin Lab Anal       Date:  1991       Impact factor: 2.352

7.  Local tolerance and systemic safety of pegaptanib sodium in the dog and rabbit.

Authors:  Jeffrey W-D Foy; Kay Rittenhouse; Marlene Modi; Manju Patel
Journal:  J Ocul Pharmacol Ther       Date:  2007-10       Impact factor: 2.671

8.  A novel anti-CEACAM5 monoclonal antibody, CC4, suppresses colorectal tumor growth and enhances NK cells-mediated tumor immunity.

Authors:  Chaogu Zheng; Jing Feng; Di Lu; Ping Wang; Shu Xing; Jean-Luc Coll; Dongling Yang; Xiyun Yan
Journal:  PLoS One       Date:  2011-06-22       Impact factor: 3.240

9.  Homophilic adhesion between Ig superfamily carcinoembryonic antigen molecules involves double reciprocal bonds.

Authors:  H Zhou; A Fuks; G Alcaraz; T J Bolling; C P Stanners
Journal:  J Cell Biol       Date:  1993-08       Impact factor: 10.539

10.  Specific carcinoembryonic antigens of the human digestive system.

Authors:  P Gold; S O Freedman
Journal:  J Exp Med       Date:  1965-09-01       Impact factor: 14.307

View more
  10 in total

Review 1.  Avoiding hepatic metastasis naturally: Lessons from the cotton top tamarin (Saguinus oedipus).

Authors:  Martin Tobi; Peter Thomas; Daniel Ezekwudo
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

2.  Blocking the attachment of cancer cells in vivo with DNA aptamers displaying anti-adhesive properties against the carcinoembryonic antigen.

Authors:  Erik W Orava; Aws Abdul-Wahid; Eric H-B Huang; Amirul Islam Mallick; Jean Gariépy
Journal:  Mol Oncol       Date:  2013-04-11       Impact factor: 6.603

3.  DNA Aptamer Technology for Personalized Medicine.

Authors:  Hang Xing; Kevin Hwang; Ji Li; Seyed-Fakhreddin Torabi; Yi Lu
Journal:  Curr Opin Chem Eng       Date:  2014-05-01       Impact factor: 5.163

4.  The carcinoembryonic antigen IgV-like N domain plays a critical role in the implantation of metastatic tumor cells.

Authors:  Aws Abdul-Wahid; Eric H-B Huang; Marzena Cydzik; Eleonora Bolewska-Pedyczak; Jean Gariépy
Journal:  Mol Oncol       Date:  2013-12-17       Impact factor: 6.603

5.  Serum-derived carcinoembryonic antigen (CEA) activates fibroblasts to induce a local re-modeling of the extracellular matrix that favors the engraftment of CEA-expressing tumor cells.

Authors:  Aws Abdul-Wahid; Marzena Cydzik; Nicholas W Fischer; Aaron Prodeus; John E Shively; Anne Martel; Samira Alminawi; Zeina Ghorab; Neil L Berinstein; Jean Gariépy
Journal:  Int J Cancer       Date:  2018-08-09       Impact factor: 7.396

6.  Agonistic CD200R1 DNA Aptamers Are Potent Immunosuppressants That Prolong Allogeneic Skin Graft Survival.

Authors:  Aaron Prodeus; Marzena Cydzik; Aws Abdul-Wahid; Eric Huang; Ismat Khatri; Reginald Gorczynski; Jean Gariépy
Journal:  Mol Ther Nucleic Acids       Date:  2014-08-26       Impact factor: 10.183

Review 7.  Aptamer‑based therapy for targeting key mediators of cancer metastasis (Review).

Authors:  Yahya Alhamhoom; Homood M As Sobeai; Sary Alsanea; Ali Alhoshani
Journal:  Int J Oncol       Date:  2022-04-15       Impact factor: 5.884

Review 8.  Aptamers as Theragnostic Tools in Prostate Cancer.

Authors:  Carlos David Cruz-Hernández; Griselda Rodríguez-Martínez; Sergio A Cortés-Ramírez; Miguel Morales-Pacheco; Marian Cruz-Burgos; Alberto Losada-García; Juan Pablo Reyes-Grajeda; Imelda González-Ramírez; Vanessa González-Covarrubias; Ignacio Camacho-Arroyo; Marco Cerbón; Mauricio Rodríguez-Dorantes
Journal:  Biomolecules       Date:  2022-07-29

9.  Novel RNA aptamers targeting gastrointestinal cancer biomarkers CEA, CA50 and CA72-4 with superior affinity and specificity.

Authors:  Qing Pan; Carmen O K Law; Mingo M H Yung; K C Han; Yuen Lam Pon; Terrence Chi Kong Lau
Journal:  PLoS One       Date:  2018-10-10       Impact factor: 3.240

10.  Targeting the PD-1/PD-L1 Immune Evasion Axis With DNA Aptamers as a Novel Therapeutic Strategy for the Treatment of Disseminated Cancers.

Authors:  Aaron Prodeus; Aws Abdul-Wahid; Nicholas W Fischer; Eric H-B Huang; Marzena Cydzik; Jean Gariépy
Journal:  Mol Ther Nucleic Acids       Date:  2015-04-28       Impact factor: 10.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.